<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16043</article-id><article-id pub-id-type="doi">10.7554/eLife.16043</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-15043"><name><surname>Chen</surname><given-names>Kuchuan</given-names></name><aff><institution content-type="dept">Program in Developmental Biology</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40065"><name><surname>Lin</surname><given-names>Guang</given-names></name><aff><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54338"><name><surname>Haelterman</surname><given-names>Nele A</given-names></name><aff><institution content-type="dept">Program in Developmental Biology</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54339"><name><surname>Ho</surname><given-names>Tammy Szu-Yu</given-names></name><aff><institution content-type="dept">Department of Neuroscience</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-38559"><name><surname>Li</surname><given-names>Tongchao</given-names></name><aff><institution content-type="dept">Program in Developmental Biology</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54340"><name><surname>Li</surname><given-names>Zhihong</given-names></name><aff><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11342"><name><surname>Duraine</surname><given-names>Lita</given-names></name><aff><institution>Howard Hughes Medical Institute, Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15052"><name><surname>Graham</surname><given-names>Brett H</given-names></name><aff><institution content-type="dept">Program in Developmental Biology</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15044"><name><surname>Jaiswal</surname><given-names>Manish</given-names></name><aff><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20263"><name><surname>Yamamoto</surname><given-names>Shinya</given-names></name><aff><institution content-type="dept">Program in Developmental Biology</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9193"><name><surname>Rasband</surname><given-names>Matthew N</given-names></name><aff><institution content-type="dept">Program in Developmental Biology</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1213"><name><surname>Bellen</surname><given-names>Hugo J</given-names></name><aff><institution content-type="dept">Program in Developmental Biology</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country><email>hbellen@bcm.edu</email></aff><xref ref-type="fn" rid="conf2"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-16110"><name><surname>Taylor</surname><given-names>J Paul</given-names></name><role>Reviewing editor</role><aff><institution>St Jude Children's Research Hospital</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>25</day><month>06</month><year>2016</year></pub-date><elocation-id>e16043</elocation-id><supplementary-material><ext-link xlink:href="elife-16043-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>18</day><month>03</month><year>2016</year></date><date date-type="accepted"><day>24</day><month>06</month><year>2016</year></date></history><permissions><copyright-statement>Â© 2016, Chen et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Chen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Mutations in <italic>Frataxin</italic> (<italic>FXN</italic>) cause Friedreich's ataxia (FRDA), a recessive neurodegenerative disorder. Previous studies have proposed that loss of <italic>FXN</italic> causes mitochondrial dysfunction, which triggers elevated reactive oxygen species (ROS) and leads to the demise of neurons. Here we describe a ROS independent mechanism that contributes to neurodegeneration in fly <italic>FXN</italic> mutants. We show that loss of <italic>frataxin homolog</italic> (<italic>fh</italic>) in <italic>Drosophila</italic> leads to iron toxicity, which in turn induces sphingolipid synthesis and ectopically activates 3-phosphoinositide dependent protein kinase-1 (Pdk1) and myocyte enhancer factor-2 (Mef2). Dampening iron toxicity, inhibiting sphingolipid synthesis by Myriocin, or reducing Pdk1 or Mef2 levels, all effectively suppress neurodegeneration in <italic>fh</italic> mutants. Moreover, increasing dihydrosphingosine activates Mef2 activity through PDK1 in mammalian neuronal cell line suggesting that the mechanisms are evolutionarily conserved. Our results indicate that an iron/sphingolipid/PDk1/Mef2 pathway may play a role in FRDA.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>D. melanogaster</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Hugo J Bellen, Reviewing editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></back></article>